Company: LNAI
Filing Date: 2025-10-15
Form Type: DEF 14A
Source: 0001731122-25-001378
Chunk: 45

Company: Lunai Bioworks Inc.
Filing Date: 2025-10-15
Form: DEF 14A
Chunk 45
---
 or are surrendered or forfeited for any reason without issuance of shares automatically become available for issuance
under the 2023 Plan.

The Company
granted options to purchase 100,000 shares of Common Stock to employees with a five-year vesting period during the year end
June 30, 2025 under the 2019 and 2023 Plan. For the year ended June 30, 2024, the Company granted options to purchase zero shares of Common
Stock to employees with a five-year vesting period under the 2019 and 2023 Plan.

The Company
granted options to purchase zero shares of Common Stock to employees with a three-year vesting period during the year end June 30, 2025
under the 2019 and 2023 Plan. For the year ended June 30, 2024, the Company granted options to purchase 36,950 shares to employees
with a three-year vesting period under the 2019 and 2023 Plan.

The Company
granted options to purchase 185,000 shares of Common Stock to employees with a two-year vesting period during the year end June
30, 2025 under the 2019 and 2023 Plan. For the year ended June 30, 2024, the Company granted options to purchase zero shares of Common
Stock to employees with a two-year vesting period under the 2019 and 2023 Plan.

During the years
ended June 30, 2025 and 2024, the Company granted options to purchase 36,290 and 42,441 shares, respectively, to the
Board of Directors and Scientific Advisory Board Members with a one-year vesting period, under the 2019 and 2023 Plan.

<div align='center'>28</div>

During the years
ended June 30, 2025 and 2024, the Company granted options to purchase 0 zero and 32,973 shares, respectively, to the
Board of Directors and Scientific Advisory Board Members with immediate vesting, under the 2019 and 2023 Plan.

During the years
ended June 30, 2025, and 2024, the Company granted options to purchase zero and 1,000 shares, respectively, for consulting services
with a one-year vesting period, under the 2019 and 2023 Plan.

On November 4,
2024, the Company issued 5,850 stock options to its former